HUMORAL IMMUNE-RESPONSE AGAINST HUMAN CYTOMEGALOVIRUS (HCMV)-SPECIFICPROTEINS AFTER HCMV INFECTION IN LUNG TRANSPLANTATION AS DETECTED WITH RECOMBINANT AND NATURALLY-OCCURRING PROTEINS
J. Vanzanten et al., HUMORAL IMMUNE-RESPONSE AGAINST HUMAN CYTOMEGALOVIRUS (HCMV)-SPECIFICPROTEINS AFTER HCMV INFECTION IN LUNG TRANSPLANTATION AS DETECTED WITH RECOMBINANT AND NATURALLY-OCCURRING PROTEINS, Clinical and diagnostic laboratory immunology, 2(2), 1995, pp. 214-218
The humoral immune response to four intracellularly located cytomegalo
virus (CMV) proteins was studied in 15 lung transplant recipients expe
riencing active CMV infections. Five patients had primary infections,
and 10 had secondary infections. Antibodies of the immunoglobulin M (I
gM) and IgG classes were measured in an enzyme-linked immunosorbent as
say (ELISA) system in which procaryotically expressed recombinant prot
eins were used as a substrate and also in a monoclonal antibody-based
capture ELISA which uses naturally occurring proteins as a substrate.
The proteins investigated were the lower matrix protein pp65 (ppUL83),
the major DNA-binding protein p52 (ppUL44), and the two immediate ear
ly proteins IE1 and IE2 (different splicing products of UL123). Higher
levels of antibodies were found to pp65 and especially to p52 than to
the immediate early antigens. Antibody levels detected in the recombi
nant protein-based ELISAs were generally lower than antibody responses
detected with the matching antigen capture ELISA. Moreover, some pati
ents appeared to have antibodies mainly to epitopes present on natural
ly occurring proteins. The antibody responses detected in both assays
were related to the viral load during infection as assessed by the CMV
antigenemia test, which is a quantitative marker for CMV load. It was
found that although epitopes on naturally occurring proteins induce h
igher antibody responses and responses in more patients, antibodies di
rected to epitopes present on the recombinant proteins were inversely
related to the viral load during a CMV infection. Therefore, antibodie
s to epitopes on the recombinant proteins might be more clinically rel
evant in this group of lung transplant recipients.